Consequently, SNHG14/miR-5590-3p repressed CD8+ T cell activity and promoted DLBCL progression through ZEB1-mediated activation of PD-1/PD-L1 immune checkpoint. This evidence concerns the gene PDCD1 and diffuse large B-cell lymphoma.